304
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluations

Recombinant FSH in the treatment of oligozoospermia

, , &
Pages 659-666 | Published online: 21 Apr 2009

Bibliography

  • Van Alphen MMA, Van de Kant HJG, De Roojj DG. Follicle-stimulating hormone stimulates spermatogenesis in the adult monkey. Endocrinology 1988;123(3):1449-55
  • Dias JA, Lindau-Shepard B, Hauer C, et al. Human follicle-stimulating hormone structure–activity relationships. Biol Reprod 1998;58(6):1331-6
  • Ulloa-Aguirre A, Timossi C, Damián-Matsumura P, et al. Role of glycosylation in function of follicle-stimulating hormone. Endocrine 1999;11(3):205-15
  • Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997;18(6):739-73
  • Gorczynska E, Spaliviero J, Handelsman DJ. The relationship between 3′,5′-cyclic adenosine monophosphate and calcium in mediating follicle-stimulating hormone signal transduction in Sertoli cells. Endocrinology 1994;134(1):293-300
  • Crépieux P, Marion S, Martinat N, et al. The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation. Oncogene 2001;20(34):4696-709
  • Tena-Sempere M, Manna PR, Huhtaniemi I. Molecular cloning of the mouse follicle-stimulating hormone receptor complementary deoxyribonucleic acid: functional expression of alternatively spliced variants and receptor inactivation by a C566T transition in exon 7 of the coding sequence. Biol Reprod 1999;60(6):1515-27
  • Moudgal NR, Sairam MR. Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates? Hum Reprod 1998;13(4):916-9
  • Matsumoto AM, Karpas AE, Bremner WJ. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle stimulating hormone is necessary for the maintenance of quantitative normal spermatogenesis in men. J Clin Endocrinol Metab 1986;62(6):1184-90
  • Mastrogiacomo I, Motta RG, Botteon S, et al. Achievement of spermatogenesis and genital tract maturation in hypogonadotropic hypogonadic subjects during long term treatment with gonadotropins or LHRH. Andrologia 1991;23(4):285-9
  • Burgues S, Calderon MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish collaborative group on male hypogonadotrophic hypogonadism. Hum Reprod 1997;12(5):980-6
  • Acosta AA, Khalifa E, Oehninger S. Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: norfolk's total experience. Hum Reprod 1992;7(8):1067-72
  • Bartoov B, Eltes F, Lunenfeld E, et al. Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 1994;61(4):727-34
  • Sigg C, Baciu M. Improvement of sperm concentration and bovine mucus penetration in idiopathic oligozoospermia by administration of pure FSH. Hum Reprod 1994;9:47
  • Merino G, Carranza-Lira S, Martinez-Chequer JC. Sperm characteristics and hormonal profile before and after treatment with follicle-stimulating hormone in infertile patients. Arch Androl 1996;37(3):197-200
  • Glander HJ, Kratzsch J. Effects of pure human follicle-stimulating hormone (pFSH) on sperm quality correlate with the hypophyseal response to gonadotropin-releasing hormone (GnRH). Andrologia 1997;29(1):23-8
  • Strehler E, Sterzik K, De Santo M, et al. The effect of follicle-stimulating hormone therapy on sperm quality: an ultrastructural mathematical evaluation. J Androl 1997;18(4):439-47
  • Paradisi R, Busacchi P, Seracchioli R, et al. Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study. Fertil Steril 2006;86(3):728-31
  • Baccetti B, Strehler E, Capitani S, et al. The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae 11). Hum Reprod 1997;12(9):1955-968
  • Acosta AA, Oehninger S, Ertunc H, et al. Possible role of pure human follicle-stimulating hormone in the treatment of severe male infertility by assisted reproduction: preliminary report. Fertil Steril 1991;55(6):1150-6
  • Matorras R, Perez C, Corcostegui B, et al. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum Reprod 1997;12(1):24-8
  • Kamischke A, Behre HM, Bergmann M, et al. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 1998;13(3):596-603
  • Ben-Rafael Z, Farhi J, Feldberg D, et al. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril 2000;73(1):24-30
  • Ashkenazi J, Bar-Hava I, Farhi J, et al. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril 1999;72(4):670-3
  • Ulloa-Aguirre A, Espinoza R, Damian-Matsumura P, et al. Immunological and biological potencies of the different molecular species of gonadotrophins. Hum Reprod 1988;3(4):491-501
  • Dahl KD, Stone MP. FSH isoforms, radioimmunoassays, bioassays, and their significance. J Androl 1992;13(1):11-22
  • de Leeuw R, Mulders J, Voortman G, et al. Structure-function relationship of recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod 1996;2(5):361-9
  • Schoot DC, Coelingh Bennink HJ, Mannaerts BM, et al. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrinol Metab 1992;74(6):1471-3
  • Schoot DC, Harlin J, Shoham Z, et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum Reprod 1994;9(7):1237-42
  • Matikainen T, De Leeuw R, Mannaerts B, et al. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects. Fertil Steril 1994;61(1):62-9
  • Shoham Z, Mannaerts B, Insler V, et al. Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil Steril 1993;59(4):738-42
  • Mannaerts B, Shoham Z, Schoot D, et al. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers. Fertil Steril 1993;59(1):108-14
  • Devroey P, Mannaerts B, Smitz J, et al. Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Hum Reprod 1994;9(6):1064-9
  • Hedon B, Out HJ, Hugues JN, et al. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial. Hum Reprod 1995;10(12):3102-6
  • Out HJ, Mannaerts BM, Driessen SG, et al. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995;10(10):2534-40
  • Balen A, Platteau P, Andersen AN, et al. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod 2007;22(7):1816-23
  • Baker VL, Fujimoto VY, Kettel LM, et al. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial. Fertil Steril 2009;91(4):1005-11
  • Kliesch S, Behre HM, Nieschlag E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril 1995;63(6):1326-8
  • Mannaerts B, Fauser B, Lahlou N, et al. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil Steril 1996;65(2):406-10
  • Bouloux PM, Nieschlag E, Burger HG, et al. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl 2003;24(4):604-11
  • Foresta C, Bettella A, Ferlin A, et al. Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. Fertil Steril 1998;69(4):636-42
  • Foresta C, Bettella A, Rossato M, et al. Inhibin B plasma concentrations in oligozoospermic subjects before and after therapy with follicle stimulating hormone. Hum Reprod 1999;14(4):906-12
  • Foresta C, Bettella A, Merico M, et al. FSH in the treatment of oligozoospermia. Mol Cell Endocrinol 2000;161(1-2):89-97
  • Foresta C, Bettella A, Merico M, et al. Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 2002;77(2):238-44
  • Foresta C, Bettella A, Garolla A, et al. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 2005;84(3):654-61
  • Aittomaki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82(6):959-68
  • Greb RR, Grieshaber K, Gromoll J, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005;90(8):4866-72
  • Behre HM, Greb RR, Mempel A, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005;15(7):451-6
  • Simoni M, Gromoll J, Höppner W, et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999;84(2):751-5
  • Asatiani K, Gromoll J, Eckardstein SV, et al. Distribution and function of FSH receptor genetic variants in normal men. Andrologia 2002;34(3):172-6
  • Ahda Y, Gromoll J, Wunsch A, et al. Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men. J Androl 2005;26(4):494-9
  • Pengo M, Ferlin A, Arredi B, et al. FSH receptor gene polymorphisms in fertile and infertile Italian men. Reprod Biomed Online 2006;13(6):795-800
  • Perez Mayorga M, Gromoll J, Behre HM, et al. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000;85(9):3365-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.